Skip to search formSkip to main contentSkip to account menu

Ondansetron Hydrochloride

Known as: Monohydrochloride, Ondansetron, Dihydrate, Ondansetron Monohydrochloride, Ondansetron Monohydrochloride 
The hydrochloride salt of the racemic form of ondansetron, a carbazole derivative and a selective, competitive serotonin 5-hydroxytryptamine type 3… 
National Institutes of Health

Related topics

Related topics

15 relations
2 ML Ondansetron 2 MG/ML InjectionAlcoholic Intoxication, ChronicDrug AllergyNausea

Narrower (3)

GR38032FSN-307Zofran

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Formulation and Evaluation of Floating tablets of Ondansetron Hydrochloride
The purpose of the present study was to develop an optimized gastric floating drug delivery system (GFDDS) containing Ondansetron… 
Highly Cited
2004
Highly Cited
2004
Transdermal Delivery of Ondansetron Hydrochloride: Effects of Vehicles and Penetration Enhancers
The effects of vehicles and penetration enhancers on the in vitro permeation of ondansetron hydrochloride (OS) across dorsal… 
2000
2000
Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex.
2000
2000
Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 4-(1,4,5,6-tetrahydroimidazo[4,5-d][1]benzoazepine-6-carbonyl)benzanili de…
Arginine vasopressin (AVP) has a dual action mainly in the periphery, i.e., vasoconstriction and water reabsorption via V1A and… 
1997
1997
The involvement of sigma receptors in the choice reaction performance deficits induced by phencyclidine.
1997
1997
Treatment of bulimia nervosa with ondansetron.
Bulimia nervosa, a chronic psychiatric disorder, is characterized by frequent episodes of binge eating followed by purging… 
1996
1996
Biochemical profile of YM992, a novel selective serotonin reuptake inhibitor with 5-HT2A receptor antagonistic activity
Review
1994
Review
1994
Oral ondansetron for preventing nausea and vomiting.
Available clinical data on the use of oral ondansetron for the prevention of nausea and vomiting in patients undergoing cancer… 
1993
1993
Hypolipidemic activity of HOE-402 is mediated by stimulation of the LDL receptor pathway.
HOE-402 (4-amino-2-[4,4-dimethyl-2-oxo-1-imidazolidinyl]-pyrimidine-5-N- [trifluoromethylphenyl]-carboxamide-monohydrochloride… 
1989
1989
Highly selective kappa-opioid analgesics. 2. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide derivatives.
This paper describes the chemical synthesis and the development of structure-activity relationships (SAR) for the kappa opioid… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)